Stock Information
ACADIA Pharmaceuticals Inc (ACAD)
Ticker Symbol: ACAD
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $4,798.03 mil
Piotroski score: 4
PE Ratio: 11.96
EPS (TTM): 2.21
Revenue (TTM): $6.59 M
Dividend Yield: N/A
ROE: 32.39%
Latest News
-
ACADIA Pharmaceuticals Inc. (ACAD) Discusses Top-Line Phase II Results From RADIANT Study of Remlifanserin in Alzheimer's Disease Psychosis - Slideshow
Thu, Sep 24, 2026 1:10 PM
-
ACADIA Pharmaceuticals' Shares Drop 10% Pre-Bell After Remlifanserin Study Misses Main Endpoint
Thu, Sep 24, 2026 11:47 AM
-
Acadia Pharmaceuticals: Remlifanserin Is In Trouble
Thu, Sep 24, 2026 11:43 AM
-
Acadia Pharmaceuticals Announces Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis (ADP)
Thu, Sep 24, 2026 11:00 AM
-
Acadia’s Remlifanserin Advances Toward Phase 3 In Alzheimer’s Psychosis Despite Narrow Miss On Primary Endpoint
Thu, Sep 24, 2026 7:04 AM
Key Financials
Financial data not available
